Gamma Interferon Assay for Cellular Immune Response in Cattle Vaccinated with FMD Vaccine Adjuvanted with Different Montanide Oils

Ehab EL-Sayed Ibrahim

Authors

Ehab EL-Sayed Ibrahim

Keywords:

Abstract

Abstract not found

Downloads

How to Cite

Gamma Interferon Assay for Cellular Immune Response in Cattle Vaccinated with FMD Vaccine Adjuvanted with Different Montanide Oils. (2015). Global Journal of Medical Research, 15(G3), 1-12. https://medicalresearchjournal.org/index.php/GJMR/article/view/1022

Download Citation

References

Soren Alexandersen, Zhidong Zhang, Alex Donaldson (2002) Aspects of the persistence of foot-and-mouth disease virus in animals-the carrier problem. 4(10), 1099-1110.

S Alexandersen, N Mowat (2005) Foot-and-Mouth Disease: Host Range and Pathogenesis. 288, 9-42.

H Bahnemann (1975) Binary ethylenimine as an inactivant for foot-and-mouth disease virus and its application for vaccine production. 47, 47-56.

H Bahnemann, J Mesquita (1987) Oiladjuvant vaccine against foot-and-mouth disease. 53, 25-30.

P Barnett, P Keel, S Reid, R Armstrong, R Statham, C Voyce, N Aggarwal, S Cox (2004) Evidence that high potency foot-and-mouth disease vaccine inhibits local virus replication and prevents the 'carrier' state in sheep. 22(9-10), 1221-1232.

D Bucafusco, Di Giacomo, S Pega, J Schammas, J Cardoso, N Capozzo, A Perez-Filgueira, M (2015) Foot-and-mouth disease vaccination induces cross-reactive IFN-γ responses in cattle that are dependent on the integrity of the 140S particles. 476, 11-18.

Y Cao (2014) Adjuvants for foot-and-mouth disease virus vaccines: recent progress Expert. 13(11), 1377-1385.

B Carr, Eric Lefevre, Miriam Windsor, Cristina Inghese, Simon Gubbins, Helen Prentice, Nicholas Juleff, Bryan Charleston (2013) CD4+ T-cell responses to foot-and-mouth disease virus in vaccinated cattle. 94(1), 97-107.

Y Cavalcanti, M Brelaz, J Neves, J Ferraz, V Pereira (2012) Role of TNF-Alpha, IFN-Gamma, and IL-10 in the Development ofPulmonary Tuberculosis. 2012, 745483.

A Childerstone, L Cedillo-Baron, M Foster-Cuevas, R Parkhouse (1999) Demonstration of bovine CD8+ T-cell responses to foot-and-mouth disease virus.. 80(3), 663-669.

S Cox, P Barnett (2009) Experimental evaluation of foot-and mouth disease vaccines for emergency use inruminants and pigs. 40(3), 13.

Carolina Cubillos, Beatriz De La Torre, Annamaria Jakab, Giorgia Clementi, Eva Borrás, Juan Bárcena, David Andreu, Francisco Sobrino, Esther Blanco (2008) Enhanced Mucosal Immunoglobulin A Response and Solid Protection against Foot-and-Mouth Disease Virus Challenge Induced by a Novel Dendrimeric Peptide. 82(14), 7223-7230.

H Cunliffe, J Graves (1963) Formalin-Treated Foot-and-Mouth Disease Virus: Comparison of Two Adjuvants in Cattle. 27(8), 193-197.

Pervaiz Dar, Ramya Kalaivanan, Nuru Sied, Bedaso Mamo, Subodh Kishore, V Suryanarayana, Ganesh Kondabattula (2013) Montanide ISA™ 201 adjuvanted FMD vaccine induces improved immune responses and protection in cattle. 31(33), 3327-3332.

V Delcenserie, D Martel, M Lamoureux, J Amiot, Y Boutin, D Roy (2008) Immunomodulatory Effects of Probiotics in the Intestinal Tract. 10(1-2), 37-54.

P Depa, Umesh Dimri, M Sharma, Rupasi Tiwari (2012) Update on epidemiology and control of Foot and Mouth Disease - A menace to international trade and global animal enterprise. 5(11), 693.

Diaz-San, F Segundo, T Rodriguez-Calvo, A De Avila, N Sevilla (2009) Immunosuppression during acute infection with foot-and-mouth disease virus in swine is mediated by IL-10.

Diaz-San, F Segundo, M Moraes, T De Los Santos, C Dias, M Grubman (2010) Interferon-induced protection against foot-and-mouth disease virus infection correlates with enhanced tissue-specific innate immune cell infiltration and interferon-stimulated gene expression. 84(4), 2063-2077.

Dong Li, Chunxue Zhou, Daliang She, Pinghua Li, Pu Sun, Xingwen Bai, Yingli Chen, Baoxia Xie, Zaixin Liu (2013) The comparison of the efficacy of swine FMD vaccine emulsified with oil adjuvant of ISA 201 VG or ISA 206 VG. 01(03), 22-25.

M Ebeid, F Hamouda, M Farag, S Mahdy (2011) Emergency vaccination of cattle against foot-and-mouth disease confers complete clinical protection in 7 days and partial protection in 4 days. 25-28.

Ehab El-Sayed Ibrahim, Mossad Wael, Amr Gamal, Safy Ismail Hassan, Akram El-Din Mahdy, Magdy Zakaria, Abdel-Atty Mahmoud (2015) Comparative study on the immuno-potentiator effect of ISA 201. 61.

Fao (2012) Foot-and-mouth disease caused by serotype SAT2 in Egypt and Libya: A regional concern for animal health in North Africa and the Middle East. 25.

M Ferreira (1976) Prubade microneutralization poraestudies de anticueropos de la fibrea fsta 13 th Centropanamericano Fiebre Aftosa. 16, 93.

Christopher Green, Elisa Scarselli, Charles Sande, Amber Thompson, Catherine De Lara, Kathryn Taylor, Kathryn Haworth, Mariarosaria Del Sorbo, Brian Angus, Loredana Siani, Stefania Di Marco, Cinzia Traboni, Antonella Folgori, Stefano Colloca, Stefania Capone, Alessandra Vitelli, Riccardo Cortese, Paul Klenerman, Alfredo Nicosia, Andrew Pollard (2015) Chimpanzee adenovirus- and MVA-vectored respiratory syncytial virus vaccine is safe and immunogenic in adults. 7(300), 300-126.

Marvin Grubman (2005) Development of novel strategies to control foot-and-mouth disease: Marker vaccines and antivirals. 33(4), 227-234.

Ratna Gurung, Auriol Purdie, Richard Whittington, Douglas Begg (2014) Cellular and humoral immune responses in sheep vaccinated with candidate antigens MAP2698c and MAP3567 from Mycobacterium avium subspecies paratuberculosis. 4.

L Habjanec, B Halassy, J Tomasić (2008) Immunomodulatory activity of novel adjuvant formulations based on Montanide ISA oil-based adjuvants and peptidoglycan monomer. 8(5), 717-724.

C Hamblin, I Barnett, R Hedger (1986) A new enzyme-linked immunosorbent assay (ELISA) for the detection of antibodies against foot-and-mouth disease virus I. Development and method of ELISA. 93(1), 115-121.

M Ilott, J Salt, R Gaskell, R Kitching (1997) Dexamethasone inhibits virus production and the secretory IgA response in oesophageal-pharyngeal fluid in cattle persistently infected with foot-and-mouth disease virus. 118(2), 181-187.

A Iyer, S Ghosh, S Singh, R Deshmukh (2000) Evaluation of three ?ready to formulate? oil adjuvants for foot-and-mouth disease vaccine production. 19(9-10), 1097-1105.

R Killington, A Stokes, J Hierholzer (1996) Virus purification. 71-89.

B Mahy, H Kangro Unknown Title. 32.

M Lombard, P-P Pastoret, A Moulin (2007) A brief history of vaccines and vaccination. 26(1), 29-48.

Ian Macpherson, Michael Stoker (1962) Polyoma transformation of hamster cell clones-an investigation of genetic factors affecting cell competence. 16(2), 147-151.

P Moonen, L Jacobs, A Crienen, A Dekker (2004) Detection of carriers of foot-and-mouth disease virus among vaccinated cattle. 103(3-4), 151-160.

Yooni Oh, Lucy Fleming, Bob Statham, Pip Hamblin, Paul Barnett, David Paton, Jong-Hyeon Park, Yi Joo, Satya Parida (1992) Interferon-γ Induced by In Vitro Re-Stimulation of CD4+ T-Cells Correlates with In Vivo FMD Vaccine Induced Protection of Cattle against Disease and Persistent Infection. 7(9), e44365.

S Parida, Y Oh, S Reid, S Cox, R Statham, M Mahapatra, J Anderson, P Barnett, B Charleston, D Paton (2006) Interferon-γ production in vitro from whole blood of foot-and-mouth disease virus (FMDV) vaccinated and infected cattle after incubation with inactivated FMDV. 24(7), 964-969.

L Philipson, Z Dinter (1963) The Role of Interferon in Persistent Infection with Foot-and-Mouth Disease Virus. 32(2), 277-285.

J Rothel, S Jones, L Corner, J Cox, P Wood (1992) The gamma‐interferon assay for diagnosis of bovine tuberculosis in cattle: conditions affecting the production of gamma‐interferon in whole blood culture. 69(1), 1-4.

C Samuel (2001) Antiviral actions of interferons. 14, 778-809.

Santos De Los, T De Avila, B Weiblen, R Grubman, M (2006) The leader proteinase of foot-andmouth disease virus inhibits the induction of beta interferon mRNA and blocks the host innate immune response. 80, 1906-1914.

Sébastien Deville, Juliette Ben Arous, François Bertrand, Laurent Dupuis (2013) MontanideTM adjuvants for stimulation of cellular immune response in FMD vaccines Tech Bull.

A Selim, N Abouzeid, A Aggour, N Sobhy (2010) Comparative Study for Immune Efficacy of Two Different Adjuvants Bivalent FMD Vaccines in Sheep. 6(10), 1292-1298.

Gregor Lawrence, Allan Saul, Andrew Giddy, Richard Kemp, David Pye (2008) Phase I trial in humans of an oil-based adjuvant SEPPIC MONTANIDE ISA 720. 15(2), 176-178.

Carolina Stenfeldt, Peter Heegaard, Anders Stockmarr, Kirsten Tjørnehøj, Graham Belsham (2011) Analysis of the acute phase responses of Serum Amyloid A, Haptoglobin and Type 1 Interferon in cattle experimentally infected with foot-and-mouth disease virus serotype O. 42(1), 66.

A Summerfield, L Guzylack-Piriou, L Harwood, K Mccullough (2009) Innate immune responses against foot-and-mouth disease virus: current understanding and future directions. 128, 205-210.

J Vilcek, G Sen (1996) Interferons and other cytokines. 375-399.

A Voller, Ann Bartlett, D Bidwell, M Clark, A Adams (1976) The Detection of Viruses by Enzyme-Linked Immunosorbent Assay (ELISA). 33(1), 165-167.

Wael Mossad, Gamal El-Din, Ehab El-Sayed Ibrahim, *, Hind Daoud, Mohamed Samir, Ali (2014) Humeral and cellular immune response of Egyptian trivalent foot and mouth disease oil vaccine in sheep. 4(4), 178-185.

C Wilkins, M Gale (2010) Recognition of viruses by cytoplasmic sensors. 22, 41-47.

Qiaohua Wu, Mario Brum, Luizinho Caron, Marla Koster, Marvin Grubman (2003) Adenovirus-Mediated Type I Interferon Expression Delays and Reduces Disease Signs in Cattle Challenged with Foot-and-Mouth Disease Virus. 23(7), 359-368.

Cenrong Zhang, Yuemin Wang, Meng Wang, Xiaoyan Su, Yisong Lu, Fei Su, Songhua Hu (2014) Rapeseed Oil and Ginseng Saponins Work Synergistically To Enhance Th1 and Th2 Immune Responses Induced by the Foot-and-Mouth Disease Vaccine. 21(8), 1113-1119.